Technology

Home Technology Page 3
Gilead to buy cancer drugmaker Immunomedics in $21 billion deal

Gilead to buy cancer drugmaker Immunomedics in $21 billion deal

Gilead Sciences will acquire biotech company Immunomedics in a $21 billion deal that will expand Gilead's availability of cancer treatments, the companies announced on Sunday.  The deal will provide…